Doctor Manan Pareek

Doctor Manan Pareek

Herlev and Gentofte Hospital, Copenhagen (Denmark)

Member of:

Dr. Manan Pareek is an MD, PhD, FAHA, FESC, currently working as a resident in internal medicine. He has co-supervised 5 masters theses and co-mentored 5 PhD-students. He has almost 15 years of teaching experience. Dr. Pareek has been a volunteer member of the Danish Society of Cardiology since 2014 where he has authored or co-authored 5 guidelines and been on the endorsement committees for two ESC guidelines (dual antiplatelet therapy and hypertension). He is also a member of the International Society of Cardiovascular Disease Epidemiology and Prevention, given his particular interest in these research areas. He has worked with hyperglycemia, insulin resistance, hypertension, biomarkers, and prediction of diabetes, cardiovascular disease, and mortality. Finally, Dr. Pareek serves as a peer reviewer for >40 journals and has reviewed abstracts for the American Heart Association and ESC since 2018. He has authored or co-authored >180 publications (>95 peer-reviewed articles).

Presentations Articles

High-sensitivity troponin-T concentrations and long-term risk of death in patients with acute pulmonary embolism

Event: ESC Congress 2023

Topic: Pulmonary Embolism (PE)

Session: Risk assessment, biomarkers, treatments of acute pulmonary embolism: are we able to impact outcomes?

Access

Serial high-sensitivity troponin-I and long-term risk of myocardial infarction and coronary revascularization in subjects with suspected acute coronary syndrome

Event: ESC Congress 2023

Topic: Biomarkers

Session: Risk stratification in acute coronary syndromes (1)

Access

Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 1

Access

Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome

Event: ESC Congress 2022

Topic: Biomarkers

Session: Biomarkers and more

Access

Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension e-posters

Access

Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension e-posters

Access

YNHHS-COVID-19 - Cardiac Complications Registry

Event: ESC Congress 2020

Topic: Epidemiology

Session: COVID and Cardiovascular Disease

Access

Serial changes in high-sensitivity troponin I levels indicate poorer prognosis in patients with suspected acute coronary syndrome who fail to reach a level greater than the 99th percentile

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Access

Baseline and on-treatment serum bicarbonate, intensive blood pressure lowering, and mortality: The Systolic Blood Pressure Intervention Trial (SPRINT)

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension ePosters

Access

The ESC algorithm for serial high-sensitivity troponin T changes and long-term outcomes in patients with suspected acute coronary syndrome

Event: ESC Congress 2020

Topic: Epidemiology, Prognosis, Outcome

Session: Acute Coronary Syndromes ePosters

Access

Doctor Manan Pareek

Biography

Contributor content

High-sensitivity troponin-T concentrations and long-term risk of death in patients with acute pulmonary embolism

Serial high-sensitivity troponin-I and long-term risk of myocardial infarction and coronary revascularization in subjects with suspected acute coronary syndrome

Blood pressure and clinical outcomes in patients with diabetes and stable coronary artery disease in THEMIS

Serial high-sensitivity troponin T concentrations and long-term outcomes in patients with suspected acute coronary syndrome

Greater event rates in high-risk patients with a history of heart disease: from the Systolic Blood Pressure Intervention Trial (SPRINT)

Marital status, cardiovascular events, and intensive blood pressure lowering among men and women in the Systolic Blood Pressure Intervention Trial

YNHHS-COVID-19 - Cardiac Complications Registry

Serial changes in high-sensitivity troponin I levels indicate poorer prognosis in patients with suspected acute coronary syndrome who fail to reach a level greater than the 99th percentile

Baseline and on-treatment serum bicarbonate, intensive blood pressure lowering, and mortality: The Systolic Blood Pressure Intervention Trial (SPRINT)

The ESC algorithm for serial high-sensitivity troponin T changes and long-term outcomes in patients with suspected acute coronary syndrome

ESC 365 is supported by